Publications by authors named "Arief Kurniadi"
Introduction: Direct oral anticoagulant (DOAC) dose adjustment is based on age, renal function, and body weight. There is a paucity of data describing the factors associated with the prescription of inappropriate dosage and their impact on clinical outcomes among patients receiving transcatheter aortic valve implantation (TAVI).
Methods: In a single-center study, 432 patients who were on long-term DOAC therapy and underwent TAVI between 2015 and 2022 were included.
Article Synopsis
- Planning noncardiac surgeries after transcatheter aortic valve implantation (TAVI) is complex and this study analyzed the results and outcomes of such surgeries in TAVI patients.
- Out of 1,602 TAVI patients, 104 underwent 148 noncardiac surgeries, with 56.7% being elective and most categorized as intermediate-risk.
- Adverse events occurred in 38.5% of these surgeries, significantly higher in high-risk procedures, indicating a greater risk of complications following high-risk surgeries.
Article Synopsis
- A hybrid strategy combining plug-based and suture-based vascular closure devices (VCDs) was studied to determine the effectiveness of ProGlide/AngioSeal versus ProGlide/FemoSeal after transcatheter aortic valve implantation (TAVI).
- A retrospective study of 608 patients revealed that the ProGlide/AngioSeal group had significantly higher rates of major bleeding and overall complications compared to the ProGlide/FemoSeal group.
- The findings suggest that using ProGlide/FemoSeal may lead to better outcomes within 30 days and that anterior wall calcification at the access site increases the risk of complications.
Article Synopsis
- * A study of 1,332 patients showed that those with an HFA-PEFF score of 5 or higher were generally older and had more health issues like atrial fibrillation and chronic kidney disease, leading to higher cardiovascular mortality and heart failure-related rehospitalization within two years.
- * However, the HFA-PEFF score alone did not significantly predict cardiovascular mortality or rehospitalization, suggesting that additional clinical variables are needed for better risk assessment in this patient population. *